home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

358 rows where filing_period = "third_quarter", filing_year = 2020 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 358 ✖

filing_year 1

  • 2020 · 358 ✖

filing_period 1

  • third_quarter · 358 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2503045 THE PETRIZZO GROUP, INC. 722bc939-29af-4b51-b7e6-55a1c5815200 3T THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2020 third_quarter MED Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2020-09-24T13:27:20.283000-04:00
2503280 CONGRESSIONAL SOLUTIONS, INC (CSI) 2b34b2d0-3b43-412f-8e2a-ec7da6fb999d Q3 CONGRESSIONAL SOLUTIONS, INC (CSI) 297237 UNIVERSITY OF NORTH TEXAS SYSTEM 2020 third_quarter MED COVID19 Research COVID 19 Testing Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-09-30T22:55:43.490000-04:00
2503296 FRANCIS EDWARD & CRONIN, INC. d9fab1de-a3c5-4f1c-91f4-f1f652cb837f Q3 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2020 third_quarter MED Issues and legislation related to Alzheimer's disease research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-10-01T07:49:50.503000-04:00
2503297 FRANCIS EDWARD & CRONIN, INC. 29c172f7-0b0e-4508-a957-203330979f63 Q3 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2020 third_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2020-10-01T07:53:50.997000-04:00
2503415 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) d8f0a72a-1a1e-4ef0-83fb-95620d1a94ae Q3 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2020 third_quarter MED Pharmaceutical labeling Food & Drug Administration (FDA) 18700   0 0 2020-10-02T10:36:44.857000-04:00
2503722 NATURAL RESOURCE RESULTS LLC ba5c4e91-e331-4b26-a5f8-758e15d96b4e Q3 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2020 third_quarter MED Support NNSA budget and approps for grants to cooperatives on medical isotope MO-99 production facility. HOUSE OF REPRESENTATIVES,SENATE,White House Office 30000   0 0 2020-10-04T10:55:08.773000-04:00
2503752 MARSHALL BRACHMAN 3fd219c5-93f5-43fd-a177-01d4885d215f Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2020 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-04T15:51:27.970000-04:00
2503961 WATKINS & EAGER PLLC 86458043-1203-4eef-8001-d0876b4de9f1 Q3 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2020 third_quarter MED Work to assist in developing a legislative strategy for funding for training & development for Fragile X clinicians & other medical providers. Encourage Members to act favorably on matters of interest related to funding & research. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2020-10-05T13:05:53.047000-04:00
2504000 HOLLAND & KNIGHT LLP 9d4e540a-0a2e-4b17-b3b9-5a8d7f76dc4e Q3 HOLLAND & KNIGHT LLP 18466 NETEERA TECHNOLOGIES LTD. 2020 third_quarter MED Contactless and remote vital sign monitoring technology. Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-10-05T13:49:08.333000-04:00
2504098 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 90e37133-7139-4887-a5a5-debd936fafed Q3 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2020 third_quarter MED NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, 340B, surprise billing legislation, screening and enrollment issues, pediatric research bill HR4519 PACT Act, COVID related testing and research. Executive ICE rule on changing status for J1 visas Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   35404 0 0 2020-10-05T16:33:48.187000-04:00
2504297 TODD STRATEGY GROUP dc8ff6f0-ad34-4094-905b-c91d72ae2822 Q3 TODD STRATEGY GROUP 401103321 ORGANIZE.ORG 2020 third_quarter MED Organ procurement policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-06T12:27:37.290000-04:00
2504396 BEN BARNES GROUP LP 5a11903c-a343-49af-9108-18f797c1fc85 Q3 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2020 third_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-10-06T15:12:28.400000-04:00
2504403 AUBURN HEALTH STRATEGIES, LLC 8d4b5a19-18d3-4466-9373-edac4b329e64 Q3 AUBURN HEALTH STRATEGIES, LLC 292697 NEUROTECH, LLC 2020 third_quarter MED EEG monitoring Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-10-06T15:29:31.693000-04:00
2504406 AUBURN HEALTH STRATEGIES, LLC fde6a4ba-e6fd-4386-9e84-eb29989c9b6f Q3 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2020 third_quarter MED Proficiency testing for clinical laboratories Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-10-06T15:39:33.587000-04:00
2504655 AMERICAN COLLEGE OF CLINICAL PHARMACY 0e14125c-af0d-4f2a-855e-d1980d99bb1b Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2020 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2020-10-07T13:29:08.140000-04:00
2505319 RAY C CULVER III 6b232a02-74a7-4358-a462-6a02c74e2960 Q3 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2020 third_quarter MED Funding for USDA ARS Human Nutrition Research Centers in the FY2021 House and Senate Agricultural Appropriations bills and finalizing the cooperative agreement for FY20 funding. HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2020-10-08T18:24:49.527000-04:00
2505460 THE CJR GROUP, INC. 22a2bad9-fd3c-4c00-a8c3-20686419f988 Q3 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2020 third_quarter MED NIH funding, mental health initiatives HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-09T10:26:36.087000-04:00
2505519 GOLDBUG STRATEGIES LLC b1545e10-607d-4377-9fee-920c351acd24 Q3 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2020 third_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-10-09T11:18:27.200000-04:00
2505592 SAINT LOUIS UNIVERSITY ea3f8c93-ba4b-48d6-ba3a-eb1b2c378e40 Q3 SAINT LOUIS UNIVERSITY 400684039 SAINT LOUIS UNIVERSITY 2020 third_quarter MED Support for infectious disease research and research related to COVID-19. HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2020-10-09T12:15:16.567000-04:00
2505678 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION f5226059-fb54-4c6c-8462-a8e6bc7747a8 Q3 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 401103437 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 2020 third_quarter MED COVID-19 Testing PPE Access Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-10-09T12:49:02.517000-04:00
2505717 FEDERAL SOLUTIONS, LLC 8d9f29a6-cb50-4368-99cc-a374990a4098 Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2020 third_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research. Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2020-10-09T13:56:33.583000-04:00
2505772 SQUIRE PATTON BOGGS c90eb463-cb5e-40a9-93a5-a9d4caad34e1 Q3 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2020 third_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2020-10-09T14:49:51.270000-04:00
2505912 MOLNLYCKE HEALTH CARE US, LLC 560d7338-9f63-4708-b7da-52021c2a4a93 Q3 MOLNLYCKE HEALTH CARE US, LLC 401104898 MOLNLYCKE HEALTH CARE US, LLC 2020 third_quarter MED Pursuance of approval from relevant agencies of a medical pilot program; gathering support from Congressional leaders. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2020-10-10T17:24:46.343000-04:00
2505955 HOLLAND & KNIGHT LLP 577d01be-624e-41c3-b32c-74c826a4774b Q3 HOLLAND & KNIGHT LLP 18466 NOVEOME BIOTHERAPEUTICS 2020 third_quarter MED Pending clinical issues before the FDA; COVID-19 pandemic related issues before Congress and the Development Finance Corporation. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-10-11T13:16:20.627000-04:00
2506600 GREEN PLAINS INC. bb6e40b7-fb6f-4c68-b585-51d9a0228cc7 Q3 GREEN PLAINS INC. 401104765 GREEN PLAINS 2020 third_quarter MED Issues related to the Novel Coronavirus and the disease COVID-19; Issues related to the production of industrial grades of alcohol for inclusion in hand sanitizer; Issues related to the transportation and tax treatment for industrial grades of alcohol for inclusion in hand sanitizer; H.R. 748, the CARES Act; H.R. 6800, the Heroes Act; Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Emergency Management Agency (FEMA),Federal Reserve System,Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   70000 0 0 2020-10-13T11:09:49.857000-04:00
2506633 SQUIRE PATTON BOGGS ab398a89-dd5b-4661-bcd7-b25de568b9ef Q3 SQUIRE PATTON BOGGS 30906 IMPACT JOURNALS, LLC 2020 third_quarter MED National Library of Medicine indexing matters. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-10-13T11:36:17.430000-04:00
2506642 BLUEBIRD STRATEGIES 6a44cc4c-b512-4ece-a2b9-b661581b39d8 Q3 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2020 third_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-10-13T11:41:29.880000-04:00
2506660 SQUIRE PATTON BOGGS e37efc0e-71d3-4aa9-aa87-1a6d62996db1 Q3 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2020 third_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-10-13T11:47:42.763000-04:00
2506666 BLUEBIRD STRATEGIES 704757c5-bdb9-4476-a83c-7f70e59a2bd2 Q3 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2020 third_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-13T11:47:45.300000-04:00
2506716 POWERS PYLES SUTTER & VERVILLE, P.C. c303da94-b636-4db8-89b5-eecd0ba65dae Q3 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 MOSES WEITZMAN HEALTH SYSTEM, INC. 2020 third_quarter MED Moving Forward Act, H.R. 2 Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136 Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127 Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800 Updated Health and Economic Recovery Omnibus Emergency Solutions Act, "The HEROES Act," H.R. 8406 Coronavirus Response Additional Supplemental Appropriations Act, 2020, S. 4320 Continuing Appropriations Act, 2021, and Other Extensions Act, H.R. 8337, now. P.L. 116-159 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill House, Senate Financial Services and General Government Appropriations Bill House, Senate Community Health Center Reauthorization Bills Pursuit of grants with federal agencies House, Senate Legislation to to Reauthorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Training Programs and Medical Assistant Training Programs House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Health Provider Consultations (E-Consults) with Related Telemedicine in Health Centers and Rural Health Clinics, H.R. 5190 House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780) Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 10000   0 0 2020-10-13T12:20:16.647000-04:00
2506802 POWERS PYLES SUTTER & VERVILLE, P.C. 36212236-a9e7-4cc2-a567-1baf6d3f5f7c Q3 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 PIH HEALTH FOUNDATION 2020 third_quarter MED Moving Forward Act, H.R. 2 Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, now P.L. 116-136 Families First Coronavirus Response Act, H.R. 6201, now P.L. 116-127 Coronavirus Preparedness and Response Supplemental Appropriations Act, H.R. 6074, now P.L. 116-123 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800 Updated Health and Economic Recovery Omnibus Emergency Solutions Act, "The HEROES Act," H.R. 8406 Coronavirus Response Additional Supplemental Appropriations Act, 2020, S.4320 Continuing Appropriations Act, 2021, and Other Extensions Act, H.R. 8337, now. P.L. 116-159 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bill House, Senate Department of Homeland Security Appropriations Bill House, Senate Department of Agriculture Appropriations Bill Pursuit of grants with Federal agencies Telemedicine House, Senate Infrastructure Bills (i.e., H.R. 2, H.R. 2741, H.R. 4780) Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 30000   0 0 2020-10-13T13:34:33.763000-04:00
2507086 K&L GATES, LLP 43e3c000-c234-4f8b-999e-fd12eb0a3978 Q3 K&L GATES, LLP 32098 NATIONAL ASSN FOR BIOMEDICAL RESEARCH 2020 third_quarter MED Issues related to medical research (no legislation). Agriculture, Dept of (USDA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) 20000   0 0 2020-10-13T16:20:37.123000-04:00
2507113 SAM ACTION, INC. 0941ae35-749f-4c9b-899f-29f1b80044c3 Q3 SAM ACTION, INC. 401104337 SAM ACTION, INC. 2020 third_quarter MED H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Small Business Administration (SBA),White House Office   20000 0 0 2020-10-13T17:10:53.370000-04:00
2507237 MCDERMOTT+ LLC 3995cf78-626c-4eca-bef9-ea1cdd80d511 Q3 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2020 third_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2020-10-14T08:18:31.160000-04:00
2507318 SQUIRE PATTON BOGGS 54c246c8-9344-4b67-8c4f-1c32b200b70e Q3 SQUIRE PATTON BOGGS 30906 NATIONAL CANNABIS ROUNDTABLE 2020 third_quarter MED Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,Treasury, Dept of,White House Office 80000   0 0 2020-10-14T10:03:58.767000-04:00
2507361 WAKE FOREST UNIVERSITY HEALTH SCIENCES 277c1a1f-8682-42c5-997a-b1904b052215 Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2020 third_quarter MED FY21 Department of Labor/HHS Appropriations bill; surprise billing Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2020-10-14T10:29:12.023000-04:00
2508024 FAEGRE DRINKER BIDDLE & REATH LLP 9ab799bc-bb48-4986-a3f2-502bb386a51e Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 GLOBAL DOWN SYNDROME FOUNDATION 2020 third_quarter MED Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2020-10-14T16:15:46.647000-04:00
2508455 MICHIGAN TECHNOLOGICAL UNIVERSITY 77efb57d-7ad8-4856-9297-2e55efd72cbd Q3 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2020 third_quarter MED Discussed issues of interest related higher education for the COVID-19 pandemic. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2020-10-15T08:18:47.857000-04:00
2508656 WINNING STRATEGIES WASHINGTON 680033cc-0201-4016-b295-2cc7a3795b18 Q3 WINNING STRATEGIES WASHINGTON 50796 I AM ALS 2020 third_quarter MED Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-10-15T10:33:42.730000-04:00
2508752 WINNING STRATEGIES WASHINGTON d80ed2c1-2c1e-4093-92c2-c70432167163 Q3 WINNING STRATEGIES WASHINGTON 50796 OLIVIAN 2020 third_quarter MED COVID-19 face mask policy and funding opportunities HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-10-15T11:00:09.033000-04:00
2508841 WINNING STRATEGIES WASHINGTON f906ee76-4fe0-4225-91d8-0c1b6aad865e Q3 WINNING STRATEGIES WASHINGTON 50796 PHILIPS NORTH AMERICA LLC 2020 third_quarter MED CARES Act programs and other COVID-19-related programs Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Indian Health Service,SENATE 10000   0 0 2020-10-15T11:12:27.673000-04:00
2508850 WINNING STRATEGIES WASHINGTON 6c992a24-305f-43a9-a3ee-d22f8f64d181 Q3 WINNING STRATEGIES WASHINGTON 50796 PHLOW CORPORATION 2020 third_quarter MED Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign manufactured medicines HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-15T11:14:30.963000-04:00
2508880 WINNING STRATEGIES WASHINGTON cef90167-922a-42af-9de2-0e182103b905 Q3 WINNING STRATEGIES WASHINGTON 50796 PREMIER MEDICAL CORPORATION 2020 third_quarter MED COVID-19 testing policy and resources HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-15T11:21:40.197000-04:00
2508911 WINNING STRATEGIES WASHINGTON e5c25881-97be-44c9-8046-df5dddc73911 Q3 WINNING STRATEGIES WASHINGTON 50796 RETRACTABLE TECHNOLOGIES INC (RTI) 2020 third_quarter MED Response to COVID-19 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-15T11:28:50.360000-04:00
2509150 THE PRENDA GROUP LLC 521dd3c8-adc3-46f2-9385-3238304bc8ad Q3 THE PRENDA GROUP LLC 401104543 UV-CONCEPTS 2020 third_quarter MED Emergency response to COVID-19 Pandemic. Assistance to Hospitals / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. CARES ACT HR HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-10-15T12:11:27-04:00
2509686 MARSHFIELD CLINIC HEALTH SYSTEM 57164d6f-2394-48cb-af91-1eb702f8ab32 Q3 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2020 third_quarter MED General research support, health care quality improvement, precision medicine Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2020-10-15T15:35:15.703000-04:00
2510175 MICHAEL N. MCCARTY LAW OFFICE PLLC 9ca052c5-d56d-4048-9732-79fd043ac0ec Q3 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2020 third_quarter MED Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; prospective legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512); Coronavirus relief and stimulus legislation as it relates to clinical laboratories and medical practices; coronavirus testing supply chain issues. HOUSE OF REPRESENTATIVES,SENATE,White House Office 10000   0 0 2020-10-15T19:31:59.310000-04:00
2510310 AMERICAN SOCIETY OF ADDICTION MEDICINE a9baaee9-2067-45a6-ba50-a72fa15e3d80 Q3 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2020 third_quarter MED Advocated for FY2021 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, increase in funding for the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, funding for preventive medicine residency programs, and $8.8 billion for discretionary Health Resources and Services Administration programs. Supported HR 3414 (and prior versions)/ S. 2892 - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits. Advocated for its inclusion in the Lower Health Care Costs Act of 2019. Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn. This bill is not specific to mental health, but it would provide significant stability to those patients and providers. Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release. Supported HR 4974/S 4640: the MATE Act - to amend the Controlled Substances Act to require physicians and other prescribers of controlled substances to complete training on treating and managing patients with opioid and other substance use disorders (which shall also satisfy certain training required to receive a waiver for dispensing narcotic drugs for maintenance or detoxification treatment),and for other purposes. Supported a conditi… Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   70000 0 0 2020-10-16T08:09:01.400000-04:00
2510350 MANATOS & MANATOS df46225a-e212-4db7-8afb-10d7272d1e3d Q3 MANATOS & MANATOS 23634 BARBARA ANN KARMANOS CANCER INSTITUTE 2020 third_quarter MED PPS-exempt cancer hospitals HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-10-16T09:07:15.103000-04:00
2510756 STANFORD UNIVERSITY 1c60a46f-a26f-4880-ba48-7728f604a7cf Q3 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2020 third_quarter MED HR6800 Health and Economic Recovery Omnibus Emergency Solutions Act HEALS Act HR8409; HR925 The Heroes Act HR8283; S4421 Temporary Reciprocity to Ensure Access to Treatment Act Health Professions Programs Graduate Medical Education Funding Pediatric GME Programs Energy, Dept of,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS)   100000 0 0 2020-10-16T11:38:51.980000-04:00
2511111 THE CONAFAY GROUP, LLC 5e231aca-9a63-4ca1-8038-89592c72b078 Q3 THE CONAFAY GROUP, LLC 401004840 HAWAII BIOTECH, INC. 2020 third_quarter MED Medical countermeasures. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-10-16T13:17:26.107000-04:00
2511118 REPUBLIC CONSULTING, LLC 57b6ec7b-e2ce-4c10-bd9e-350ca836d0ee Q3 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2020 third_quarter MED Monitor Data and Science policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-10-16T13:18:27.680000-04:00
2511353 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 83605c15-9800-485f-b795-8bab578f25e4 Q3 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2020 third_quarter MED H.R. 7614 Labor HHS - Education Appropriations (NIH) CARES Act funding H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act" HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   10000 0 0 2020-10-16T14:19:24.867000-04:00
2511416 BURRELL INTERNATIONAL GROUP LLC 3ecc26bf-d442-4cdd-8fcc-91d687361cb8 Q3 BURRELL INTERNATIONAL GROUP LLC 401103483 SMALL BIOTECHNOLOGY BUSINESS COALITION 2020 third_quarter MED Monitoring Legislation for VALID Act and Laboratory Diagnostic Testing developments; No specific activity, nor contacts.       0 0 2020-10-16T14:36:45.717000-04:00
2511428 BRACEWELL LLP a72fb33c-dac7-4d2f-a24c-8d54892ac0a2 Q3 BRACEWELL LLP 6837 NATIONAL BRAIN TUMOR SOCIETY 2020 third_quarter MED work related to the advancement of the Cancer Drug Coverage Parity Act and PCHETA (H.R. 647); Peer-review cancer research; Drug pricing and shortages; COVID-19 Response Issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-10-16T14:38:49.650000-04:00
2511458 CAPITOL COUNSEL LLC a97df4b6-98bc-4113-944a-8869600d4c53 Q3 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2020 third_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-16T14:40:02.523000-04:00
2511505 THE CONAFAY GROUP, LLC d6a52533-63f8-4234-b3a2-a6c564f13d29 Q3 THE CONAFAY GROUP, LLC 401004840 ACADIA PHARMACEUTICALS INC. 2020 third_quarter MED Pharmaceutical research. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-10-16T14:50:19.307000-04:00
2511518 BURRELL INTERNATIONAL GROUP LLC b94f8f57-864e-4503-89f6-e8670e022562 Q3 BURRELL INTERNATIONAL GROUP LLC 401103483 HOMOLOGY MEDICINES 2020 third_quarter MED Drug pricing and gene therapy, generally; H.R. 4393 - Advancing Access to Precision Medicine; H.R. 2507/S. 2158 Newborn Screening Saves Lives Reauthorization Act; H.R. 8045 - Genome Editing Threat Assessment Act; HR 2501 - Medical Nutrition Equity Act; HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-10-16T14:54:22.630000-04:00
2511745 THE CONAFAY GROUP, LLC 512f22cd-f12f-4900-a576-edccb1c8c3b4 Q3 THE CONAFAY GROUP, LLC 401004840 EMERJA, INC. (FORMERLY KNOWN AS WHEEL BIOLOGY, INC.) 2020 third_quarter MED Seek support for research and development funding Health & Human Services, Dept of (HHS) 10000   0 0 2020-10-16T15:58:32.677000-04:00
2511809 MCALLISTER & QUINN, LLC 440d7698-1ee9-45dd-9dd4-f3a5bbd10f52 Q3 MCALLISTER & QUINN, LLC 292573 CEDARS-SINAI MEDICAL CENTER 2020 third_quarter MED Firefighter cancer research, Congressionally Directed Medical Research Programs (CDMRP) re. healthcare/medical research. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2020-10-16T16:07:43.613000-04:00
2511818 THE CONAFAY GROUP, LLC 2f46aab8-8f67-4239-ba37-838ceccfa8b3 Q3 THE CONAFAY GROUP, LLC 401004840 LUNGPACER MEDICAL USA, INC 2020 third_quarter MED Seek support for research and development funding. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS) 10000   0 0 2020-10-16T16:13:46.560000-04:00
2511868 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY e8880b88-00ca-4c29-8d90-040fbcb961d6 Q3 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2020 third_quarter MED Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases; Laboratory Access for Beneficiaries (LAB) Act; issues related to COVID-19 response and laboratory test capacity Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,Veterans Affairs, Dept of (VA),White House Office   32000 0 0 2020-10-16T16:19:54.723000-04:00
2511896 THE CONAFAY GROUP, LLC 352c9d53-4031-45f3-a4bc-bcb13fd86b5b Q3 THE CONAFAY GROUP, LLC 401004840 NABRIVA THERAPEUTICS US, INC. 2020 third_quarter MED Support for medical countermeasure procurement. Health & Human Services, Dept of (HHS)     0 0 2020-10-16T16:27:02.393000-04:00
2511920 THE CONAFAY GROUP, LLC 8a02ebda-42aa-46a5-91e6-8f63e1624ef0 Q3 THE CONAFAY GROUP, LLC 401004840 CENTIVAX 2020 third_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-10-16T16:31:08.470000-04:00
2512092 THE CONAFAY GROUP, LLC b84dfc19-3071-45f3-a693-e30f37d44dc3 Q3 THE CONAFAY GROUP, LLC 401004840 ATEA PHARMACEUTICALS, INC. 2020 third_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-16T16:56:54.617000-04:00
2512120 MCHUGH LEMAY ASSOC., LLC 44cf30cf-49af-4b29-82a4-10982ad462e7 Q3 MCHUGH LEMAY ASSOC., LLC 401105253 CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2020 third_quarter MED Issues related to COVID testing - no specific leghislation. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-10-16T17:01:04.840000-04:00
2512164 THE CONAFAY GROUP, LLC 6856c669-f9c2-4bca-bcd4-55a242bb3c49 Q3 THE CONAFAY GROUP, LLC 401004840 PHASEBIO PHARMACEUTICALS, INC 2020 third_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-10-16T17:16:21.057000-04:00
2512317 THE CONAFAY GROUP, LLC f352ebbe-5443-428f-930f-2a5ae4bbe1f8 Q3 THE CONAFAY GROUP, LLC 401004840 EMERGEX VACCINES HOLDING LTD. 2020 third_quarter MED Influenza and respiratory disease research SENATE     0 0 2020-10-16T18:02:52.363000-04:00
2512322 THE CONAFAY GROUP, LLC 5d7926eb-ba31-49de-8b46-82470c830d43 Q3 THE CONAFAY GROUP, LLC 401004840 PREACTIVE TECHNOLOGIES, INC. 2020 third_quarter MED Traumatic Brain Injury Prevention SENATE     0 0 2020-10-16T18:05:53.333000-04:00
2512327 TOWNSEND PUBLIC AFFAIRS, INC 56ed90e1-789f-4903-b129-15853334d30f Q3 TOWNSEND PUBLIC AFFAIRS, INC 54734 CITY OF PARLIER 2020 third_quarter MED health benefits legislation HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE 7500   0 0 2020-10-16T18:07:54.050000-04:00
2512332 THE CONAFAY GROUP, LLC 336ab40c-3fc8-4301-96f7-74e050e1e2ee Q3 THE CONAFAY GROUP, LLC 401004840 ROIVANT SCIENCES, INC. 2020 third_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-10-16T18:10:55.877000-04:00
2512493 IMPACT HEALTH POLICY PARTNERS 8805842c-c22f-4f4d-b037-71c025b08918 Q3 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2020 third_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2020-10-16T22:40:49.020000-04:00
2512495 IMPACT HEALTH POLICY PARTNERS 68fa8332-052b-4824-9d67-2172d1f88391 Q3 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2020 third_quarter MED Issues related to research funding, NIH and other matters. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-16T22:54:50.380000-04:00
2512499 IMPACT HEALTH POLICY PARTNERS 6912c9f3-3959-44da-bc48-120e831b3ead Q3 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2020 third_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-16T23:17:51.720000-04:00
2512920 FAEGRE DRINKER BIDDLE & REATH LLP 7296df17-b044-485e-a5a3-35f30880f707 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2020 third_quarter MED Issues related to anti-microbial resistance and neglected tropical diseases.   10000   0 0 2020-10-17T15:40:37.397000-04:00
2512921 FAEGRE DRINKER BIDDLE & REATH LLP f4f75c6e-6030-416d-9350-78c39d812e7e Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2020 third_quarter MED Public Health Programs for Infectious and Tropical Disease; HR 7308 - The RISE Act; S.474, a bill to address the public health risks posed by wildlife markets, and for other purposes. Office of Management & Budget (OMB) 50000   0 0 2020-10-17T15:41:37.793000-04:00
2512939 FAEGRE DRINKER BIDDLE & REATH LLP 055b38e7-96ef-4813-b415-1d98e5716a9b Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 SIMON WILLIAMS PHARMA CONSULTING (SWPC) LLC 2020 third_quarter MED Pandemic preparedness. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-17T15:47:42.140000-04:00
2513192 OGR 3da83d90-1246-44f5-9092-fade1f0c500a Q3 OGR 48827 SMITHS GROUP PLC 2020 third_quarter MED Medical device technology related to the opioid epidemic and the COVID-19 pandemic. H.R.5172/S.3067, NOPAIN Act. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2020-10-18T00:01:55.793000-04:00
2513259 FORBES-TATE 44322b8f-1fa6-43c8-adcc-118e0c4a58c8 Q3 FORBES-TATE 400976792 AMGEN USA, INC. 2020 third_quarter MED Issues related to Biosimilars. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-10-18T09:06:42.263000-04:00
2513478 OGR c5aa905f-1d61-47dc-879d-22029af90add Q3 OGR 48827 WEAVR HEALTH 2020 third_quarter MED COVID-19 serology issues   10000   0 0 2020-10-18T12:21:53.153000-04:00
2513485 THE PETRIZZO GROUP, INC. f1d79ed0-78cd-4f45-b571-8dcc1afdeb76 Q3 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2020 third_quarter MED Funding for NIH research; H.R. 4159, PACT Act. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2020-10-18T12:57:56.387000-04:00
2513495 THE PETRIZZO GROUP, INC. 804af85a-028f-42d1-a09b-cb7ca42b46c2 Q3 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2020 third_quarter MED Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. The Human Projectome Project, a comprehensive Atlas of cell types in human brain and the Mouse Connectome Project for BRAIN Initiative Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2020-10-18T13:00:57.920000-04:00
2513496 THE PETRIZZO GROUP, INC. 7b03161e-3098-427c-8d32-7c86a2f0a96b Q3 THE PETRIZZO GROUP, INC. 305932 CEL-SCI CORPORATION 2020 third_quarter MED Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled. LEAPS COVID-19 Immunotherapyas a new immune-based treatment for COVID-19 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Vice President of the U.S. 50000   0 0 2020-10-18T13:02:58.370000-04:00
2513500 THE PETRIZZO GROUP, INC. 3f1104c4-19d8-447e-8472-7d765d0711b5 Q3 THE PETRIZZO GROUP, INC. 305932 ACCESS TO ADVANCED HEALTH INSTITUTE 2020 third_quarter MED Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; support adjuvant inclusion in COVID-19 countermeasures. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2020-10-18T13:03:59.307000-04:00
2513642 BROWNSTEIN HYATT FARBER SCHRECK, LLP f9fc22ea-08e8-48cc-96d9-2394c03be47d Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ABBVIE 2020 third_quarter MED Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 60000   0 0 2020-10-18T15:25:32.587000-04:00
2513916 BROWNSTEIN HYATT FARBER SCHRECK, LLP 56c3eb12-608b-4e03-ae3e-09b9e64763c6 Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ANTHEM, INC. 2020 third_quarter MED Issues related to Medicare H.R. 748 CARES Act - Issues related to COVID-19 relief HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2020-10-18T19:16:50.217000-04:00
2513978 PARALYZED VETERANS OF AMERICA e4b8b0d7-6904-4bd9-ba6c-255c7b7d605e Q3 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2020 third_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues AMTRAK - Natl Railroad Passenger Corporation,Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Architectural & Transportation Barriers Compliance Board (ACCESS),Veterans Affairs, Dept of (VA),Veterans Employment & Training Service   78368 0 0 2020-10-18T21:32:11.223000-04:00
2514011 THE NICKLES GROUP, LLC f0d5116a-b535-4c76-b97d-c434e5d655b7 Q3 THE NICKLES GROUP, LLC 293335 MYRIAD GENETICS, INC. 2020 third_quarter MED S 3404, VALID Act and regulation of pharmcogenomic tests. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2020-10-18T21:50:17.507000-04:00
2514159 FOLEY & LARDNER LLP e062ffc0-e953-4665-bf4e-8716ddbfb040 Q3 FOLEY & LARDNER LLP 15042 NOVOCURE INC. 2020 third_quarter MED Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, and before the Department of Health and Human Services, sub-agencies, and staffs to each, with respect to coverage and pricing issues; review relevant statutes and regulations regarding same. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2020-10-18T22:44:57.873000-04:00
2514202 FOLEY & LARDNER LLP f0fbc217-2f14-4679-ac26-6f1ef895fc71 Q3 FOLEY & LARDNER LLP 15042 SHINE MEDICAL TECHNOLOGIES 2020 third_quarter MED Implementation of American Medical Isotope Production Act       0 0 2020-10-18T22:59:06.323000-04:00
2514403 VAN SCOYOC ASSOCIATES fe2c38e4-b172-4e36-b99d-c4666e553648 Q3 VAN SCOYOC ASSOCIATES 39837 ARUP LABORATORIES, INC. 2020 third_quarter MED H.R.6102, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, Diagnostic Lab Testing Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act, COVID-19 Laboratory Testing related issues Public Law 116-139, Paycheck Protection Program and Health Care Enhancement Act, COVID-19 Laboratory Testing related issues Future Coronavirus relief related issues, COVID-19 Laboratory Testing related issues Monitor COVID-19 Laboratory Testing related issues, as follows: Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020 Public Law 116-127, Families First Coronavirus Response Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-19T06:42:56.477000-04:00
2514471 VAN SCOYOC ASSOCIATES d1b62b1c-9088-458e-8ae2-858b4d65753a Q3 VAN SCOYOC ASSOCIATES 39837 GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION 2020 third_quarter MED CDC, Infectious Diseases Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020, Higher Education research related issues; and SARS-CoV2 issues Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act, Higher Education research related issues; and SARS-CoV2 issues E-Cigarettes related issues Monitor the following: Agency for Healthcare Research and Quality Medicaid Disparities NIH Public Health Research Centers in Minority Institutions HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-19T07:34:09.863000-04:00
2514480 VAN SCOYOC ASSOCIATES 1a831718-cde2-4532-a75e-837c55f71faa Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF TOLEDO 2020 third_quarter MED Higher Education research related issues; and SARS-CoV2 issues, as follows: Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020 Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2020-10-19T07:36:10.937000-04:00
2514640 UC HEALTH 664e68df-ea2c-4955-a6bd-ee5b7c69f206 Q3 UC HEALTH 401103195 UC HEALTH 2020 third_quarter MED COVID19 Testing Equipment and Supplies (swabs, reagents), convalescent plasma studies, Moderna Vaccine Trial, Operation Warp Speed Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2020-10-19T09:05:43.447000-04:00
2514878 VAN SCOYOC ASSOCIATES 0a33385c-eef8-439b-a6f5-4f5211347102 Q3 VAN SCOYOC ASSOCIATES 39837 MEDICAL COLLEGE OF WISCONSIN 2020 third_quarter MED H.R.4764, Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019 or the TRANSPLANT Act of 2019", Reauthorization related issues Monitor Healthcare research and development related issues, as follows: Department of Defense Medical research issues H.R.7613, Energy and Water Development and Related Agencies Appropriations Act, FY2021 H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021 H.R.7616, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2021 Public Law 116-136, Coronavirus Aid Relief and Economic Security (CARES) Act, Implementation issues SENATE 30000   0 0 2020-10-19T09:40:46.960000-04:00
2514885 BROWNSTEIN HYATT FARBER SCHRECK, LLP dd7e2994-5687-4a40-96a8-6b88cd43c081 Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 BAXTER HEALTHCARE CORPORATION 2020 third_quarter MED Availability of medical products HOUSE OF REPRESENTATIVES 30000   0 0 2020-10-19T09:41:48.523000-04:00
2514906 K&L GATES, LLP 5b5064b7-e8f0-48a2-bec7-f97469165f3b Q3 K&L GATES, LLP 32098 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 2020 third_quarter MED Export restrictions for research models from China -- no specific legislation. New facilities for research models -- no specific legislation. Federal Aviation Administration (FAA),White House Office 10000   0 0 2020-10-19T09:45:54.007000-04:00
2514958 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH ab795d1d-ef12-477a-b7bb-4ec3c650aea5 Q3 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2020 third_quarter MED Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   67782 0 0 2020-10-19T09:54:05.583000-04:00
2515016 VAN SCOYOC ASSOCIATES 5b5ac6e3-58ed-4291-a79e-590a89f9e023 Q3 VAN SCOYOC ASSOCIATES 39837 MEDICAL UNIVERSITY HOSPITAL AUTHORITY 2020 third_quarter MED Monitor Medical research and development related issues: National Institutes of Health and various institutes and bureaus thereof Health Resources Services Administration HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2020-10-19T09:57:13.767000-04:00
2515073 THE CONAFAY GROUP, LLC aacd737e-f3ae-47c7-ad12-66d2af3f921c Q3 THE CONAFAY GROUP, LLC 401004840 CIDARA THERAPEUTICS, INC. 2020 third_quarter MED Support for research on viral diseases HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2020-10-19T10:02:27.190000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2397.188ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API